EDRONAX reboxetine 4mg (as mesilate) tablet blister pack

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 20718009e48bf9a2
Product Name: EDRONAX reboxetine 4mg (as mesilate) tablet blister pack
Artg Id: 79745
Artg Name: EDRONAX reboxetine 4mg (as mesilate) tablet blister pack
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2001-08-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/30ef2943c7c03498be77cf5fbd762e03.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d5ee3d3031f238e73bd8f6980babf7c6.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 31, 2025

Approval ID

20718009e48bf9a2

Type

Standard